Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial

被引:0
|
作者
Mant, Jonathan [1 ]
Modi, Rakesh N. [1 ]
Dymond, Andrew [1 ]
Armstrong, Natalie [2 ]
Burt, Jenni [3 ]
Calvert, Peter [4 ]
Cowie, Martin [5 ]
Ding, Wern Yew [4 ]
Edwards, Duncan [1 ]
Freedman, Ben [6 ]
Griffin, Simon J. [7 ,8 ]
Hoare, Sarah [9 ]
Hobbs, F. D. Richard [10 ]
Johnson, Rachel [11 ]
Kaptoge, Stephen [12 ]
Lip, Gregory Y. H. [4 ,13 ]
Lobban, Trudie [14 ]
Lown, Mark [15 ]
Lund, Jenny [16 ]
McManus, Richard J. [10 ]
Mills, Mark T. [4 ]
Morris, Stephen [9 ]
Powell, Alison [17 ]
Proietti, Riccardo [4 ]
Sutton, Stephen [9 ]
Sweeting, Mike [12 ]
Thom, Howard [11 ]
Williams, Kate [1 ]
机构
[1] Univ Cambridge, Primary Care Unit, Strangeways Res Lab, Cambridge, England
[2] Univ Leicester, Dept Populat Hlth Sci, Leicester, England
[3] THIS Labs, Cambridge, England
[4] Liverpool Heart & Chest Hosp NHS Fdn Trust, Liverpool, England
[5] Kings Coll London, Sch Cardiovasc & Metab Med & Sci, London, England
[6] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia
[7] Univ Cambridge, Inst Publ Hlth, Primary Care Unit, Cambridge, England
[8] MRC Epidemiol Unit, Cambridge, England
[9] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England
[10] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[11] Univ Bristol, Bristol, England
[12] Cambridge Biomed Campus, Cambridge, England
[13] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
[14] Arrhythmia Alliance & AF Assoc, Stratford Upon Avon, England
[15] Univ Southampton, Sch Primary Care Populat Sci & Med Educ, Southampton, England
[16] Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England
[17] Univ Cambridge, THIS Inst, Cambridge, England
来源
BMJ OPEN | 2024年 / 14卷 / 04期
基金
美国国家卫生研究院; 英国惠康基金;
关键词
Primary Care; Mass Screening; Stroke; Randomized Controlled Trial; CARDIOLOGY; COGNITIVE DECLINE; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction There is a lack of evidence that the benefits of screening for atrial fibrillation (AF) outweigh the harms. Following the completion of the Screening for Atrial Fibrillation with ECG to Reduce stroke (SAFER) pilot trial, the aim of the main SAFER trial is to establish whether population screening for AF reduces incidence of stroke risk.Methods and analysis Approximately 82 000 people aged 70 years and over and not on oral anticoagulation are being recruited from general practices in England. Patients on the palliative care register or residents in a nursing home are excluded. Eligible people are identified using electronic patient records from general practices and sent an invitation and consent form to participate by post. Consenting participants are randomised at a ratio of 2:1 (control:intervention) with clustering by household. Those randomised to the intervention arm are sent an information leaflet inviting them to participate in screening, which involves use of a handheld single-lead ECG four times a day for 3 weeks. ECG traces identified by an algorithm as possible AF are reviewed by cardiologists. Participants with AF are seen by a general practitioner for consideration of anticoagulation. The primary outcome is stroke. Major secondary outcomes are: death, major bleeding and cardiovascular events. Follow-up will be via electronic health records for an average of 4 years. The primary analysis will be by intention-to-treat using time-to-event modelling. Results from this trial will be combined with follow-up data from the cluster-randomised pilot trial by fixed-effects meta-analysis.Ethics and dissemination The London-Central National Health Service Research Ethics Committee (19/LO/1597) provided ethical approval. Dissemination will include public-friendly summaries, reports and engagement with the UK National Screening Committee.Trial registration number ISRCTN72104369.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial
    Marleen Kunneman
    Megan E. Branda
    Peter A. Noseworthy
    Mark Linzer
    Bruce Burnett
    Sara Dick
    Gabriela Spencer-Bonilla
    Cara A. Fernandez
    Haeshik Gorr
    Mike Wambua
    Shelly Keune
    Claudia Zeballos-Palacios
    Ian Hargraves
    Nilay D. Shah
    Victor M. Montori
    Trials, 18
  • [32] Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial
    Kunneman, Marleen
    Branda, Megan E.
    Noseworthy, Peter A.
    Linzer, Mark
    Burnett, Bruce
    Dick, Sara
    Spencer-Bonilla, Gabriela
    Fernandez, Cara A.
    Gorr, Haeshik
    Wambua, Mike
    Keune, Shelly
    Zeballos-Palacios, Claudia
    Hargraves, Ian
    Shah, Nilay D.
    Montori, Victor M.
    TRIALS, 2017, 18
  • [33] Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
    Asberg, Signild
    Hijazi, Ziad
    Norrving, Bo
    Terent, Andreas
    Ohagen, Patrik
    Oldgren, Jonas
    TRIALS, 2017, 18
  • [34] Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
    Signild Åsberg
    Ziad Hijazi
    Bo Norrving
    Andreas Terént
    Patrik Öhagen
    Jonas Oldgren
    Trials, 18
  • [35] Supporting Treatment decision making to Optimise the Prevention of STROKE in Atrial Fibrillation: The STOP STROKE in AF study. Protocol for a cluster randomised controlled trial
    Melina Gattellari
    John M Worthington
    Dominic Y Leung
    Nicholas Zwar
    Implementation Science, 7
  • [36] Supporting Treatment decision making to Optimise the Prevention of STROKE in Atrial Fibrillation: The STOP STROKE in AF study. Protocol for a cluster randomised controlled trial
    Gattellari, Melina
    Worthington, John M.
    Leung, Dominic Y.
    Zwar, Nicholas
    IMPLEMENTATION SCIENCE, 2012, 7
  • [37] DEPRESCRIBING IN FRAIL OLDER PEOPLE: PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL
    Potter, K. B.
    Flicker, L.
    Beer, C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 163 - 164
  • [38] OPTIMAL TIMING OF ANTICOAGULATION AFTER ACUTE ISCHEMIC STROKE WITH ATRIAL FIBRILLATION (OPTIMAS): A RANDOMISED CONTROLLED TRIAL
    Werring, D.
    Ahmed, N.
    Best, J.
    Bordea, E.
    Cohen, H.
    Dehbi, H-M
    Engelter, S.
    Freemantle, N.
    Gill, A.
    Hunter, R.
    James, M.
    Jayanthi, A.
    Lip, G.
    Massingham, S.
    Nash, P.
    Ndoutoumou, A.
    Norrving, B.
    Sims, H.
    Sprigg, N.
    Vanniyasingham, T.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 51 - 51
  • [39] Implantable loop recorder detection of atrial fibrillation to prevent stroke ( The LOOP Study): a randomised controlled trial
    Svendsen, Jesper H.
    Diederichsen, Soren Z.
    Hojberg, Soren
    Krieger, Derk W.
    Graff, Claus
    Kronborg, Christian
    Olesen, Morten S.
    Nielsen, Jonas B.
    Holst, Anders G.
    Brandes, Axel
    Haugan, Ketil J.
    Kober, Lars
    LANCET, 2021, 398 (10310): : 1507 - 1516
  • [40] Screening for Atrial Fibrillation in the Older Population A Randomized Clinical Trial
    Gladstone, David J.
    Wachter, Rolf
    Schmalstieg-Bahr, Katharina
    Quinn, F. Russell
    Hummers, Eva
    Ivers, Noah
    Marsden, Tamara
    Thornton, Andrea
    Djuric, Angie
    Suerbaum, Johanna
    von Gruenhagen, Doris
    McIntyre, William F.
    Benz, Alexander P.
    Wong, Jorge A.
    Merali, Fatima
    Henein, Sam
    Nichol, Chris
    Connolly, Stuart J.
    Healey, Jeff S.
    JAMA CARDIOLOGY, 2021, 6 (05) : 558 - 567